Expert insight: Ask of any blend claiming synergy: at what ratio, for what endpoint, against which additivity model
AtSERAT2;1, -3;1, and -3;2 are sulfenylated on the same conserved cysteine (Cys150 in AtSERAT2;1, Cys122 in AtSERAT3;1, and Cys159 in AtSERAT3;2), whereas AtSERAT2;2 is sulfenylated on two cysteines that are not conserved among Arabidopsis SERAT
Because the compound is unproven in people and material sold as a research chemical is not manufactured to pharmaceutical standards, the full profile of potential effects is uncharacterised
For the nanoprecipitation method, PLGA polymer was dissolved in a suspension of DDA-GSH-AuNCs in dichloromethane (DCM) (after the phase transfer) and the resulting mixture was added drop wise into ethanol (non-solvent for PLGA and non-suspending medium for DDA-GSH-AuNCs) resulting in the formation of PLGA nanoparticles loaded with DDA-GSH-AuNCs (cartoon for the encapsulation process is sketched in Fig
annuum in HR
Who is a good candidate for glutathione Therapy